{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:39Z","timestamp":1792787979534,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Guangxi Natural Science Foundation","award":["2023GXNSFAA026002"],"award-info":[{"award-number":["2023GXNSFAA026002"]}]},{"name":"the Guangxi Scientific Research and Technological Development Foundation","award":["GuikeAB21220062"],"award-info":[{"award-number":["GuikeAB21220062"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160418"],"award-info":[{"award-number":["82160418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02553-x","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:22:45Z","timestamp":1768789365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["METTL3-mediated m6A modification of CACNA1E promotes osteosarcoma progression and chemoresistance by enhancing WNT7B-mediated Ca2+ signaling"],"prefix":"10.1186","volume":"25","author":[{"given":"Chaotao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanchang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"2553_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02105-9","volume":"23","author":"S Yu","year":"2024","unstructured":"Yu S, Yao X. Advances on immunotherapy for osteosarcoma. Mol Cancer. 2024;23:192.","journal-title":"Mol Cancer"},{"key":"2553_CR2","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.24121","volume":"115","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115:1531\u201343.","journal-title":"Cancer"},{"key":"2553_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00409-y","volume":"8","author":"HC Beird","year":"2022","unstructured":"Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, et al. Osteosarcoma. Nat Rev Dis Primers. 2022;8:77.","journal-title":"Nat Rev Dis Primers"},{"key":"2553_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","volume":"109","author":"S Smeland","year":"2019","unstructured":"Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, et al. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019;109:36\u201350.","journal-title":"Eur J Cancer"},{"key":"2553_CR5","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1200\/JCO.2014.60.0734","volume":"33","author":"SS Bielack","year":"2015","unstructured":"Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, et al. Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: first results of the EURAMOS-1 good response randomized controlled trial. J Clin Oncol. 2015;33:2279\u201387.","journal-title":"J Clin Oncol"},{"key":"2553_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.mayocp.2012.01.015","volume":"87","author":"CA Arndt","year":"2012","unstructured":"Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012;87:475\u201387.","journal-title":"Mayo Clin Proc"},{"key":"2553_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1158\/0008-5472.CAN-23-1307","volume":"84","author":"Y Xu","year":"2024","unstructured":"Xu Y, Deng C, Chen H, Song Y, Xu H, Song G, et al. Osteosarcoma cells secrete CXCL14 that activates integrin \u03b111\u03b21 on fibroblasts to form a lung metastatic niche. Cancer Res. 2024;84:994\u20131012.","journal-title":"Cancer Res"},{"key":"2553_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41388-023-02880-7","volume":"43","author":"M Ma","year":"2024","unstructured":"Ma M, Zhuang J, Li H, Mi R, Song Y, Yang W, et al. Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-\u03b2 signaling feedback loop. Oncogene. 2024;43:47\u201360.","journal-title":"Oncogene"},{"key":"2553_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3724\/abbs.2024084","volume":"56","author":"L Wang","year":"2024","unstructured":"Wang L, Zhai D, Tang L, Zhang H, Wang X, Ma N, et al. FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy. Acta Biochim Biophys Sin. 2024;56:1289\u201399.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2553_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1158\/2159-8290.CD-17-1152","volume":"9","author":"LC Sayles","year":"2019","unstructured":"Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, et al. Genome-informed targeted therapy for osteosarcoma. Cancer Discov. 2019;9:46\u201363.","journal-title":"Cancer Discov"},{"key":"2553_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2022.07.004","volume":"33","author":"S Zheng","year":"2023","unstructured":"Zheng S, Wang X, Zhao D, Liu H, Hu Y. Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications. Trends Cell Biol. 2023;33:312\u201323.","journal-title":"Trends Cell Biol"},{"key":"2553_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.molcel.2020.04.017","volume":"78","author":"S Marchi","year":"2020","unstructured":"Marchi S, Giorgi C, Galluzzi L, Pinton P. Ca(2+) fluxes and cancer. Mol Cell. 2020;78:1055\u201369.","journal-title":"Mol Cell"},{"key":"2553_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43475-w","volume":"14","author":"M Sampedro-Casta\u00f1eda","year":"2023","unstructured":"Sampedro-Casta\u00f1eda M, Baltussen LL, Lopes AT, Qiu Y, Sirvio L, Mihaylov SR, et al. Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability. Nat Commun. 2023;14:7830.","journal-title":"Nat Commun"},{"key":"2553_CR14","doi-asserted-by":"publisher","first-page":"7284","DOI":"10.1158\/1078-0432.CCR-06-1567","volume":"12","author":"R Natrajan","year":"2006","unstructured":"Natrajan R, Little SE, Reis-Filho JS, Hing L, Messahel B, Grundy PE, et al. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms\u2019 tumors. Clin Cancer Res. 2006;12:7284\u201393.","journal-title":"Clin Cancer Res"},{"key":"2553_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2022.102527","volume":"102","author":"SH Gao","year":"2022","unstructured":"Gao SH, Wang GZ, Wang LP, Feng L, Zhou YC, Yu XJ, et al. Mutations and clinical significance of calcium voltage-gated channel subunit alpha 1E (CACNA1E) in non-small cell lung cancer. Cell Calcium. 2022;102:102527.","journal-title":"Cell Calcium"},{"key":"2553_CR16","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/j.pain.0000000000000971","volume":"158","author":"J Gandla","year":"2017","unstructured":"Gandla J, Lomada SK, Lu J, Kuner R, Bali KK. Mir-34c-5p functions as pronociceptive microrna in cancer pain by targeting Cav2.3 containing calcium channels. Pain. 2017;158:1765\u201379.","journal-title":"Pain"},{"key":"2553_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1121787","volume":"13","author":"MA Sarabia-S\u00e1nchez","year":"2023","unstructured":"Sarabia-S\u00e1nchez MA, Moreno-Londo\u00f1o AP, Casta\u00f1eda-Patl\u00e1n MC, Alvarado-Ortiz E, Mart\u00ednez-Morales JC, Robles-Flores M. Non-canonical Wnt\/Ca2+ signaling is essential to promote self-renewal and proliferation in colon cancer stem cells. Front Oncol. 2023;13:1121787.","journal-title":"Front Oncol"},{"key":"2553_CR18","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.7150\/jca.46547","volume":"11","author":"X Qiao","year":"2020","unstructured":"Qiao X, Niu X, Shi J, Chen L, Wang X, Liu J, et al. Wnt5a regulates ameloblastoma cell migration by modulating mitochondrial and cytoskeletal dynamics. J Cancer. 2020;11:5490\u2013502.","journal-title":"J Cancer"},{"key":"2553_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01706-6","volume":"22","author":"Y Tian","year":"2023","unstructured":"Tian Y, Xiao H, Yang Y, Zhang P, Yuan J, Zhang W, et al. Crosstalk between 5-methylcytosine and N(6)-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma. Mol Cancer. 2023;22:5.","journal-title":"Mol Cancer"},{"key":"2553_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101200","volume":"79","author":"X Fan","year":"2025","unstructured":"Fan X, Han F, Wang H, Shu Z, Qiu B, Zeng F, et al. YTHDF2-mediated m(6)A modification of ONECUT2 promotes stemness and oxaliplatin resistance in gastric cancer through transcriptionally activating TFPI. Drug Resist Updat. 2025;79:101200.","journal-title":"Drug Resist Updat"},{"key":"2553_CR21","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.7150\/ijbs.82081","volume":"19","author":"C Wang","year":"2023","unstructured":"Wang C, Meng Y, Zhao J, Ma J, Zhao Y, Gao R, et al. Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3\/m(6)A\/ATG5 axis. Int J Biol Sci. 2023;19:2289\u2013303.","journal-title":"Int J Biol Sci"},{"key":"2553_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13344","volume":"56","author":"F Yang","year":"2023","unstructured":"Yang F, Liu Y, Xiao J, Li B, Chen Y, Hu A, et al. Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15. Cell Prolif. 2023;56:e13344.","journal-title":"Cell Prolif"},{"key":"2553_CR23","doi-asserted-by":"crossref","unstructured":"Wei X, Feng J, Chen L, Zhang C, Liu Y, Zhang Y, et al. METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1. Cancer Lett. 2024;611:217194.","DOI":"10.1016\/j.canlet.2024.217194"},{"key":"2553_CR24","doi-asserted-by":"crossref","unstructured":"DG, JZ, YC, YX, JM, GH, et al. The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1\/2 phosphorylation and MMP9 signaling pathway. J Exp Clin Cancer Res. 2019;38:233.","DOI":"10.1186\/s13046-019-1223-y"},{"key":"2553_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101114","volume":"76","author":"X Niu","year":"2024","unstructured":"Niu X, Liu W, Zhang Y, Liu J, Zhang J, Li B, et al. Cancer plasticity in therapy resistance: mechanisms and novel strategies. Drug Resist Updat. 2024;76:101114.","journal-title":"Drug Resist Updat"},{"key":"2553_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01804-z","volume":"22","author":"M Jiang","year":"2023","unstructured":"Jiang M, Jike Y, Liu K, Gan F, Zhang K, Xie M, et al. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol Cancer. 2023;22:113.","journal-title":"Mol Cancer"},{"key":"2553_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13578","volume":"57","author":"Y Jin","year":"2024","unstructured":"Jin Y, Fan Z. New insights into the interaction between m6A modification and lncRNA in cancer drug resistance. Cell Prolif. 2024;57:e13578.","journal-title":"Cell Prolif"},{"key":"2553_CR28","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.omtn.2022.01.013","volume":"27","author":"X Huang","year":"2022","unstructured":"Huang X, Guo H, Wang L, Yang L, Shao Z, Zhang W. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer. Mol Ther Nucleic Acids. 2022;27:947\u201355.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2553_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13404","volume":"56","author":"Y Su","year":"2023","unstructured":"Su Y, Wang B, Huang J, Huang M, Lin T. YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer. Cell Prolif. 2023;56:e13404.","journal-title":"Cell Prolif"},{"key":"2553_CR30","first-page":"69","volume":"23","author":"X Huang","year":"2023","unstructured":"Huang X, Wang L, Guo H, Zhang W. Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization. Bioact Mater. 2023;23:69\u201379.","journal-title":"Bioact Mater"},{"key":"2553_CR31","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-21-2106","volume":"82","author":"P Yadav","year":"2022","unstructured":"Yadav P, Subbarayalu P, Medina D, Nirzhor S, Timilsina S, Rajamanickam S, et al. M6A RNA methylation regulates histone ubiquitination to support cancer growth and progression. Cancer Res. 2022;82:1872\u201389.","journal-title":"Cancer Res"},{"key":"2553_CR32","volume":"43","author":"Y Sahin","year":"2025","unstructured":"Sahin Y, Altan Z, Saadat K, Ikeda MA, Arslan A. Investigating miR-30a\u2019s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma. Biochem Biophys Rep. 2025;43:102122.","journal-title":"Biochem Biophys Rep"},{"key":"2553_CR33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cbin.11797","volume":"46","author":"R Hayat","year":"2022","unstructured":"Hayat R, Manzoor M, Hussain A. Wnt signaling pathway: a comprehensive review. Cell Biol Int. 2022;46:863\u201377.","journal-title":"Cell Biol Int"},{"key":"2553_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13686","volume":"57","author":"T Liu","year":"2024","unstructured":"Liu T, Wen Y, Cui Z, Chen H, Lin J, Xu J, et al. Microrna-3061 downregulates the expression of PAX7\/Wnt\/Ca(2+) signalling axis genes to induce premature ovarian failure in mice. Cell Prolif. 2024;57:e13686.","journal-title":"Cell Prolif"},{"key":"2553_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy N, Kurzrock R. Targeting the Wnt\/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50\u201360.","journal-title":"Cancer Treat Rev"},{"key":"2553_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12834-x","volume":"10","author":"J Benkert","year":"2019","unstructured":"Benkert J, Hess S, Roy S, Beccano-Kelly D, Wiederspohn N, Duda J, et al. Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson\u2019s disease. Nat Commun. 2019;10:5094.","journal-title":"Nat Commun"},{"key":"2553_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317753121","volume":"121","author":"L Gao","year":"2024","unstructured":"Gao L, Ardiel E, Nurrish S, Kaplan JM. Voltage-induced calcium release in Caenorhabditis elegans body muscles. Proc Natl Acad Sci USA. 2024;121:e2317753121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2553_CR38","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1002\/jcb.29451","volume":"121","author":"H Cui","year":"2020","unstructured":"Cui H, Zhao J. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p\/WNT7B axis. J Cell Biochem. 2020;121:2284\u201393.","journal-title":"J Cell Biochem"},{"key":"2553_CR39","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1080\/15384101.2019.1676087","volume":"18","author":"Q Liu","year":"2019","unstructured":"Liu Q, Wang Z, Zhou X, Tang M, Tan W, Sun T, et al. Mir-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to doxorubicin through targeting Wnt7b. Cell Cycle. 2019;18:3325\u201336.","journal-title":"Cell Cycle"},{"key":"2553_CR40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41422-020-0370-1","volume":"30","author":"K Matsuoka","year":"2020","unstructured":"Matsuoka K, Bakiri L, Wolff LI, Linder M, Mikels-Vigdal A, Pati\u00f1o-Garc\u00eda A, et al. Wnt signaling and Loxl2 promote aggressive osteosarcoma. Cell Res. 2020;30:885\u2013901.","journal-title":"Cell Res"},{"key":"2553_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02828-5","volume":"42","author":"K Tan","year":"2023","unstructured":"Tan K, Lu W, Chen F, Shi H, Ma Y, Chen Z, et al. CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma. J Exp Clin Cancer Res. 2023;42:250.","journal-title":"J Exp Clin Cancer Res"},{"key":"2553_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jhep.2024.12.038","volume":"83","author":"R Dong","year":"2025","unstructured":"Dong R, Wang T, Dong W, Zhang H, Li Y, Tao R, et al. TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway. J Hepatol. 2025;83:105\u201318.","journal-title":"J Hepatol"},{"key":"2553_CR43","doi-asserted-by":"crossref","unstructured":"Zhuang H, Dang Y, Sun L, Hong D, Zhai S, Shao X, Liu G, Sun X, Dong C, Ma X, et al. SAE1 emerges as a pan-cancer driver and key regulator of HCC metastasis. J Adv Res. 2025.","DOI":"10.1016\/j.jare.2025.06.028"},{"key":"2553_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01409-4","volume":"20","author":"Y Mo","year":"2021","unstructured":"Mo Y, Wang Y, Zhang S, Xiong F, Yan Q, Jiang X, et al. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Mol Cancer. 2021;20:112.","journal-title":"Mol Cancer"},{"key":"2553_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0880-6","volume":"37","author":"X Xiao","year":"2018","unstructured":"Xiao X, Wang W, Li Y, Yang D, Li X, Shen C, et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp Clin Cancer Res. 2018;37:201.","journal-title":"J Exp Clin Cancer Res"},{"key":"2553_CR46","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1158\/0008-5472.CAN-24-0163","volume":"84","author":"W Zhang","year":"2024","unstructured":"Zhang W, Li W, Yin C, Feng C, Liu B, Xu H, et al. PRKDC induces chemoresistance in osteosarcoma by recruiting GDE2 to stabilize GNAS and activate AKT. Cancer Res. 2024;84:2873\u201387.","journal-title":"Cancer Res"},{"issue":"5","key":"2553_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41388-023-02882-5","volume":"43","author":"M He","year":"2024","unstructured":"He M, Wang Y, Xie J, Pu J, Shen Z, Wang A, et al. M(7)G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma. Oncogene. 2024;43(5):341\u201353.","journal-title":"Oncogene"},{"key":"2553_CR48","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s43587-024-00670-8","volume":"4","author":"Z Song","year":"2024","unstructured":"Song Z, Park SH, Mu WC, Feng Y, Wang CL, Wang Y, et al. An NAD(+)-dependent metabolic checkpoint regulates hematopoietic stem cell activation and aging. Nat Aging. 2024;4:1384\u201393.","journal-title":"Nat Aging"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02553-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:46:13Z","timestamp":1772451973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02553-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2553"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02553-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each patient provided written informed consent for the collection of clinical samples, and the study protocols were approved by the Ethics Committee of Guangxi Medical University Cancer Hospital (2024-D100-01). The animal experiments were approved by the Animal Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (2023-S476-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}